Retatrutide Phase 2 Clinical Trial (NCT05934110)
In June, Novo abruptly said it was calling off its deal with Hims & Hers and accused the company of illegal mass compounding and deceptive marketing. Prime Day is here again and Amazons subscription service has never been more popular Well, its that time of year again: many have made their wish lists, people are scraping together the money theyve saved to pick out a perfect gift, some are presumably leaving out refreshments for the weary delivery drivers and, more and more, drones
No other GLP-1 medication has produced comparable liver results
Sharps disposal: Used needles, syringes, or auto-injector devices must be placed in an approved sharps bin not in household waste or recycling
GLP-1s are generally well tolerated, with most gastrointestinal side effects subsiding over time
The goal is to gradually reach the higher doses that produced the best results in clinical trials